Why did Tesla's Full Self-Driving test raise safety concerns?
How did veteran analyst view stocks, bonds, and gold today?
What impact do Taiwan's export controls have on Huawei and SMIC?
Why did Trump veto Israel’s plan to assassinate Iran’s leader?
How is the Israel-Iran conflict affecting global stock futures?
Why is BT planning major job cuts due to AI?
What caused Chime's stock to surge after IPO?
Sarepta reports second patient death after treatment with Duchenne gene therapy
statnews.com/2025/06/15/duchenne-sarepta-gene-therapy-elevidys-patient-death
Sarepta Therapeutics said Sunday that it was halting shipments of its Duchenne muscular dystrophy gene therapy for patients who can no longer walk, following the death of a second person who received the treatment.
Sarepta disclosed the first patient death — a 16-year-old boy — in March.…
This story appeared on statnews.com, 2025-06-15 11:45:16.080000.